| Factors influencing SARS-CoV-2 RNA concentrations in wastewater up to the sampling stage: A systematic review X Bertels, P Demeyer, S Van den Bogaert, T Boogaerts, ALN van Nuijs, ... Science of the Total Environment 820, 153290, 2022 | 76 | 2022 |
| Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study M Grymonprez, TL De Backer, X Bertels, S Steurbaut, L Lahousse Frontiers in pharmacology 14, 1125576, 2023 | 23 | 2023 |
| Evaluating the impact of COVID-19 countermeasures on alcohol consumption through wastewater-based epidemiology: A case study in Belgium T Boogaerts, X Bertels, B Pussig, M Quireyns, L Toebosch, ... Environment International 170, 107559, 2022 | 13 | 2022 |
| Lung-function trajectories: relevance and implementation in clinical practice E Melén, R Faner, JP Allinson, D Bui, A Bush, A Custovic, ... The Lancet, 2024 | 9 | 2024 |
| Time series modelling for wastewater-based epidemiology of COVID-19: A nationwide study in 40 wastewater treatment plants of Belgium, February 2021 to June 2022 X Bertels, S Hanoteaux, R Janssens, H Maloux, B Verhaegen, P Delputte, ... Science of The Total Environment 899, 165603, 2023 | 4 | 2023 |
| Do the lockdown-imposed changes in a wastewater treatment plant catchment's socio-demographics impact longitudinal temporal trends in psychoactive pharmaceutical use? T Boogaerts, M Quireyns, H De Loof, X Bertels, N Van Wichelen, B Pussig, ... Science of The Total Environment 876, 162342, 2023 | 4 | 2023 |
| Clinical relevance of lung function trajectory clusters in middle-aged and older adults X Bertels, JC Ross, R Faner, MH Cho, MA Ikram, GG Brusselle, ... ERJ Open Research 10 (1), 2024 | 1 | 2024 |
| The implementation of risk minimization measures to prevent teratogenic pregnancy outcomes related to oral retinoid and valproate use in Belgium X Bertels, E Mehuys, K Boussery, L Lahousse Acta Clinica Belgica 77 (5), 815-822, 2022 | 1 | 2022 |
| Benefits of angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers on progression of emphysema and lung function decline X Bertels, L Lahousse Chest 160 (4), 1160-1162, 2021 | 1 | 2021 |
| Effect of Pharmacotherapy on Lung Function Trajectories in the General Population L Lahousse, X Bertels, GG Brusselle, B Stricker D13. DETERMINANTS OF DISEASE PROGRESSION AND DECLINE IN COPD, A6912-A6912, 2024 | | 2024 |
| All-Cause Mortality of STAR-categorized Patients with COPD Among the General Population X Bertels, S Riemann, D Vauterin, L Lahousse, GG Brusselle American Journal of Respiratory and Critical Care Medicine, 2024 | | 2024 |
| Understanding the aetiology of lung function impairment: the crucial role of age of onset X Bertels, L Lahousse thorax 79 (2), 106-107, 2024 | | 2024 |
| Phenotyping asthma with airflow obstruction in middle-aged and older adults: a CADSET clinical research collaboration X Bertels, A Edris, J Garcia-Aymerich, R Faner, H Meteran, T Sigsgaard, ... BMJ open respiratory research 10 (1), e001760, 2023 | | 2023 |
| The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study M Grymonprez, TL De Backer, X Bertels, S Steurbaut, L Lahousse Europace 25 (Supplement_1), euad122. 201, 2023 | | 2023 |
| Teratogeniciteit bij orale retinoïden en valproaat X Bertels, L Lahousse FARMAZINE (GENT), 8-10, 2021 | | 2021 |
